Biofrontera Inc reports results for the quarter ended in December - Earnings Summary

Biofrontera

08/04/2022 14:31

* Biofrontera Inc  BFRI.OQ  reported a quarterly adjusted
loss
of 15 cents​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of 18 cents per share.
    * Revenue was $9.17 million​;  analysts expected $9.24
million. 
    * Biofrontera Inc's reported EPS for the quarter was a loss
of
$1.29​.
    * The mean earnings estimate of analysts had fallen by
about 56.5%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Biofrontera Inc shares had risen by 21.3% this quarter and
lost 46.3% so far this year.
    * The company reported a quarterly loss of $14.51 million.
    * Wall Street's median 12-month price target for Biofrontera
Inc
is $15.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated April 8 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated